Filing Details

Accession Number:
0001140361-14-009355
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-24 18:21:27
Reporting Period:
2014-02-18
Filing Date:
2014-02-24
Accepted Time:
2014-02-24 18:21:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1379006 Nanoviricides Inc. NNVC Services-Commercial Physical & Biological Research (8731) 760674577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1513285 Anil Diwan 135 Wood Street
West Haven CT 06516
President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-18 10,000 $3.58 1,976,347 No 4 P Direct
Common Stock Acquisiton 2014-02-18 5,000 $3.30 1,981,347 No 4 P Direct
Common Stock Acquisiton 2014-02-18 5,000 $3.57 1,986,347 No 4 P Direct
Common Stock Acquisiton 2014-02-18 5,000 $3.55 1,991,347 No 4 P Direct
Common Stock Acquisiton 2014-02-18 5,000 $3.62 1,996,347 No 4 P Direct
Common Stock Acquisiton 2014-02-18 5,000 $3.52 2,001,347 No 4 P Direct
Common Stock Acquisiton 2014-02-20 15,000 $3.80 2,016,347 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 285,714 shares issuable upon exercise of options. Does not include 285,714 shares of the Company's Series A Convertible Preferred Stock ("Series A") or 9,531,429 shares of common stock and 2,050,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.